| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3776 |
| Trial ID | NCT06285279 |
| Disease | Lupus Nephritis | Vasculitis | Membranous Nephropathy |
| Altered gene | BCMA|CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | FKC288 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Evaluation of the Safety and Efficacy of FKC288 in Participants With Autoimmune Kidney Diseases: A Single-center Exploratory Clinical Study |
| Year | 2024 |
| Country | China |
| Company sponsor | Nanjing University School of Medicine |
| Other ID(s) | NJCT-2401 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||